Laurent Pharmaceuticals is a clinical stage biopharmaceutical company focusing on life-threatening inflammatory and fibrotic diseases that are inadequately addressed by current anti-inflammatory therapies.


Dr. Larry Lands, M.D., Ph.D.

Larry C. Lands, M.D., Ph.D., professor of Pediatrics at McGill University, is director of Pediatric Respiratory Medicine and Director of the Pediatric Cystic Fibrosis Clinic at the Montreal Children’s Hospital-McGill University Health Centre. He is the cystic fibrosis consultant to the Quebec Lung Transplant Program at Centre Hospitalier de Université de Montréal-Hôpital Notre Dame. He has played leadership roles in both the American and Canadian Thoracic Societies and Cystic Fibrosis Canada. Dr. Lands’ expertise is in translational research related to inflammation, nutrition, and functional ability in children and adults with cystic fibrosis. He is internationally recognized for his work related to modulation of inflammation and exercise limitation in cystic fibrosis. His research program involves both fundamental and clinical studies in both children and adult aimed at bolstering immune defenses and functional ability in chronic lung diseases, such as cystic fibrosis and asthma. Dr. Lands received his M.D. from McGill University and his Ph.D. from McMaster University. He completed his residency and fellowship in pediatric pulmonology at the Montreal Children’s Hospital-McGill University Health Centre and has been on faculty since 1992.

Read More »
Michael W. Konstan, M.D.

Michael W. Konstan, MD is the Vice Dean for Translational Research and the Gertrude Lee Chandler Tucker Professor of Pediatrics at Case Western Reserve University School of Medicine, where he directs The Clinical and Translational Science Collaborative of Cleveland as the PI of the Case Western Reserve University School of Medicine’s NIH NCATS Clinical and Translational Science Award (CTSA). An internationally renowned physician-scientist specializing in cystic fibrosis, Dr. Konstan’s innovative work has led to novel therapies, early detection through newborn screening and extending significantly the lives of children with Cystic Fibrosis. Dr. Konstan has published more than 200 peer-reviewed publications and book chapters. He has presented more than 200 abstracts at scientific meetings and conferences, both nationally and internationally. He serves on multiple advisory boards and committees of the CF Foundation, the NIH and the FDA, all related to advancing the treatment of cystic fibrosis. He is highly sought after for presenting at major meetings both nationally and internationally, and is regarded as an expert in this disease worldwide. Dr. Konstan was the 2013 recipient of the Case Western Reserve Medal for Excellence in Health Science Innovation by the School of Medicine. He is a member of the American Pediatric Society, American Academy of Pediatrics, American Thoracic Society, and Society for Pediatric Research.

See More »
Dr. Steven Freedman, M.D., Ph.D.

Steven D. Freedman, M.D., Ph.D., is director of the Pancreas Center at Beth Israel Deaconess Medical Center (BIDMC), chief of the Division of Translational Research, and professor of medicine at Harvard Medical School. He has played a leadership role in clinical translational research both at Beth Israel Deaconess Medical Center and Harvard Medical School. Dr. Freedman’s is an internationally recognized leader in these areas with an extensive research program that encompasses both basic science as well as clinical trials of new therapies for pancreatitis, primary sclerosing cholangitis and cystic fibrosis. His collaborative work with Dr. Camilia Martin in the department of neonatology at BIDMC has led to new insights into how fatty acids and nutrition may predispose preterm infants to chronic lung disease and infection. Dr. Freedman holds a Ph.D. from Yale University School of Medicine and an M.D. from the University of Connecticut. He completed his residency and fellowship in gastroenterology at Beth Israel Hospital and has remained on faculty since 1991.

Go »
Dr. Elias Matouk, M.D.

Elias Matouk, M.D., is a Medical Director of the Adult CF Clinic of McGill University Health Centre at the Montreal Chest Institute for and an Associate Professor of Medicine at McGill. Dr. Matouk’s has over 25 years clinical expertise in caring for adult patients with cystic fibrosis and he is an expert is establishing of scoring system which allow to quantify differences in disease severity among CF patients. Dr. Matouk is member of Cystic Fibrosis Translational Research Centre (CFTRc), which works with industrial partners to develop new therapeutics for cystic fibrosis.

Dr. Camellia Martin, MD

Camilia R. Martin, M.D., M.S., is an assistant professor of pediatrics at Harvard Medical School, and the associate director of the Neonatal Intensive Care Unit and director for Cross-Disciplinary Research Partnerships in the division of translational research at Beth Israel Deaconess Medical Center (BIDMC). Dr. Martin’s research interests are focused on neonatal nutrition and its impact on health and disease in the preterm infant. Dr. Martin holds an M.D. from Cornell University School of Medicine and a master’s in epidemiology from Harvard School of Public Health. She completed her internship and residency at Children’s Memorial Hospital/Northwestern School of Medicine, where she also served as chief pediatric resident in 1996. Dr. Martin completed her fellowship in perinatal-neonatal medicine at the Harvard Combined Program in Neonatology.